Virtual HIPAA Privacy and Security Summit

Content of the training for the Virtual HIPAA Privacy and Security Summit is appropriate for attorneys, compliance officers, human resources professionals, managers, nurses, medical assistants, healthcare professionals, and business associates in the healthcare setting.

WILMINGTON, Del. (PRWEB)
October 01, 2021

The Virtual HIPAA Privacy and Security Summit is a joint effort of Widener University Delaware Law School and First Healthcare Compliance to provide resources and increase understanding for professionals facing the challenges of HIPAA compliance. The online event will be held on November 18, 2021, with a schedule that is convenient for professionals across the United States to gain an understanding of current risks and solutions. Registration is open to the public, with discounts available to First Healthcare Compliance clients and alumni of Delaware Law School.

Expert attorneys will provide six hours of education that covers a range of relevant topics and answer timely questions related to HIPAA privacy and security including Notice of Privacy Practices, Business Associates, employee training, patient rights, safeguards, electronic health records, breaches, cybersecurity, and more.

Attendees are eligible to receive 6 CLE credits (5 substantive, 1 ethics) in Delaware, New Jersey, and Pennsylvania. This program has been approved for 6 continuing education unit(s) by Practice Management Institute® and PAHCOM. The Compliance Certification Board (CCB)® has approved this event for up to 7.2 live CCB CEUs based on a 50-minute hour. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor. Sponsors of the event include the Professional Association of Health Care Office Managers (PAHCOM) and Weiner Benefits.

Content of the training for the Virtual HIPAA Privacy and Security Summit is appropriate for attorneys, compliance officers, human resources professionals, managers, nurses, medical assistants, healthcare professionals, and business associates in the healthcare setting. The schedule for the online learning event:

9:00 a.m.-9-30 a.m. Virtual Conference Opens/ Introductory Remarks

9:30 a.m.-10:30 a.m. Rachel V. Rose, JD, MBA:

The Intersection Between HIPAA, Cybersecurity, & Fraud, Waste, and Abuse

10:30 a.m.-10:40 a.m. break

10:40 a.m.-11:40 a.m. C. Trey Scott:

Under Pressure: Reporting Requirements with OCR for Breaches

11:40 a.m.-11:50 a.m. break

11:50 a.m.-12:50 p.m. Sheba E. Vine, Esq., CIPP/US:

Data Privacy in 2021

12:50 p.m.-1:20 p.m. lunch

1:20 p.m. -2:20 p.m. Kathleen W. McNicholas, MD, JD, CHC, CCEP:

Ethics and HIPAA: Pivots, Guardrails, and Good Faith

2:20 p.m. -2:30 p.m. break

2:30 p.m. -3:30 p.m. Iliana L. Peters:

Next Level Security Incident Response: Do You Speak IT?

3:30 p.m. -3:40 p.m. break

3:40 p.m. -4:40 p.m. Jennifer Gimler Brady:

Business Associate Agreements: What They Are, Who Needs Them, and How They Can Go Sideways

Share article on social media or email:

M&S Clinical Trial Suite (CTS)

NILES, Ill. (PRWEB)
October 01, 2021

M&S Technologies introduces the DVA-5000 for Clinical Trial ETDRS and Contrast Sensitivity Function Testing

M&S Technologies today announced the first of six new enhancements to their Clinical Trial Suite (CTS). CTS has a new dedicated product that specifically addresses the needs of glaucoma and retina trial sponsors and researchers. The automated-testing protocols used in the DVA-5000 are significantly more efficient and accurate compared to traditional testing methods.

“We’re experiencing increased interest in Contrast Sensitivity Function and ETDRS testing from sponsors of glaucoma and retina clinical trials,” said Joe Marino, Founder and Global Head of M&S Technologies. “Investigator Sites utilizing CTS testing protocols appreciate the significant time savings compared to their past experience with traditional testing methods. Additionally, with CTS, Biotechnicians are no longer concerned about erroneous data generated from the investigator sites due to human-error during paper documentation and related calculation errors,” he said.

CTS test results are automatically calculated and ready for review as letter score, logMAR, decimal score, and Snellen equivalent. Secure and trusted reports are immediately available in XML or CSV format for export to any EDC, Reading Center, or other location of choice.

Most importantly, the FDA recognizes CTS testing modules as an acceptable method of testing in all phases of clinical trials, including PMA trials. Over the past number of years, CTS has been used in more than 140 clinical trials, including 40 active trials, and is the industry leader and the number one choice of clinical trial sponsors for computerized vision testing.

All CTS modules, including the DVA-5000, provide accurate, consistent, and repeatable paperless test results from site-to-site and visit-to-visit.

For more information on the Clinical Trial Suite (CTS) modules, please call 1-847-763-0500.

About M&S Technologies:

M&S Technologies, a HILCO Vision Company founded in 1990 is a software development and device manufacturer, rooted in state-of-the art software development, local manufacturing, and superior customer service. M&S is known worldwide for leading technological advancements in visual testing systems. M&S is dedicated to bringing high quality, extremely accurate testing products to eye-care professionals, optometry schools and universities.

http://www.mstech-eyes.com

jmarino@mstech-eyes.com

Share article on social media or email:

Solveig Hofvind PhD, head of the Section for Breast Cancer Screening at the Cancer Registry of Norway

“This study, the first with Norwegian radiologists using 3D mammography, shows how AI can improve the efficiency of the radiologist’s workflow by enhancing cancer detection without affecting reading time.”

NIJMEGEN, Netherlands (PRWEB)
October 01, 2021

Transpara breast care AI system is in clinical use in more than 25 countries worldwide, where it has received endorsement from more peer-reviewed clinical trials than any other breast AI product.

And now, Radiology, an important publication, reveals details of more benefits of using Transpara breast AI with 3D mammography.

The latest paper is a collaboration between Norway and the Netherlands, by M.C. Pinto, A. Rodriguez-Ruiz, K. Pedersen, S. Hofvind, J. Wicklein, S. Kappler, R. M. Mann, I. Sechopoulos entitled: “Impact of Artificial Intelligence Decision Support Using Deep Learning on Breast Cancer Screening Interpretation with Single-View Wide-Angle Digital Breast Tomosynthesis.”

Radiology 2021; 000:1–8 (https://pubs.rsna.org/doi/10.1148/radiol.2021204432)

Key points:

In a retrospective observer study of 190 digital breast tomosynthesis examinations, the average detection performance of radiologists was higher when interpreting images with artificial intelligence (AI) support than when interpreting images without AI support (area under the receiver operating characteristic curve: 0.88 vs 0.85; P = .01).

Sensitivity improved with AI support (86% vs 81%; P = .006), with no differences in specificity (73% vs 71%; P = .48) or reading time (48 seconds vs 45 seconds; P = .35) being demonstrated.

The study concludes: Using a single-view digital breast tomosynthesis (DBT) and AI permits a more effective screening program with higher performance, especially in terms of an increase in cancers detected, than using single-view DBT alone.

Transpara, which is based on deep learning technology, is FDA cleared and CE marked for both 2D and 3D mammography. This means radiologists who began by applying it for 2D mammography can make a seamless transition to 3D without the costs of new hardware. In addition, this study highlights the improvements in accuracy that can be realised using AI as decision support.

Solveig Hofvind PhD, head of the Section for Breast Cancer Screening at the Cancer Registry of Norway and of BreastScreen Norway, one of the investigators in the study said, “This study, the first with Norwegian radiologists using 3D mammography, shows how AI can improve the efficiency of the radiologist’s workflow by enhancing cancer detection without affecting reading time.”

Natasja Janssen, Medical Affairs Lead at ScreenPoint Medical, commented, “Our clinical partners continue to help with this most extensive and robust body of evidence for the use of Transpara in both 2D and 3D mammography, across multiple vendors and with mammograms from a wide range of demographics in many countries. Transpara has been used in more than 1.6 million mammograms – proof that ScreenPoint Medical is delivering on its mission to bring effective AI to the fight against breast cancer.”

For more information http://www.screenpoint-medical.com

Contact for ScreenPoint

Nicki Bryan (USA)

nicki.bryan@screenpointmed.com

+1 412 208 5991

David Lee (Europe + ROW)

david.lee@screenpointmed.com

+44 (0) 7470 299 318

Share article on social media or email:

Dr. Joseph A. Bordieri

I focus a lot on my patients’ lifestyle habits because I am a firm believer that we truly are what we eat and bodies in motion tend to stay in motion. People who eat healthy and stay active on average live longer and have more active, productive, and happy lives.

SCOTCH PLAINS, N.J. (PRWEB)
October 01, 2021

New Jersey native, Dr. Joseph A. Bordieri has been reviewed and approved by NJ Top Docs for 2021. Dr. Bordieri is committed to providing the best care to his patients as a board certified Family Practice physician.

“I focus a lot on my patients’ lifestyle habits because I am a firm believer that we truly are what we eat and bodies in motion tend to stay in motion. People who eat healthy and stay active on average live longer and have more active, productive, and happy lives,” says Dr. Bordieri.

At Dr. Bordieri’s Jamesburg, New Jersey practice, Central Jersey Family Medical Group, PA, he provides the best evidence-based and compassionate medical care available to all of his patients.

Dr. Bordieri is affiliated with Robert Wood Johnson University Hospital in New Brunswick.

To learn more about Dr. Joseph A. Bordieri, please click here: https://njtopdocs.com/nj-doctors/drjosephbordieri/

—-

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:

WCG CenterWatch

FALLS CHURCH, Va. (PRWEB)
September 30, 2021

Perspectives on Clinical Trial Agreements:

What Sites, Sponsors and Stakeholders Need

CenterWatch Management Report

https://www.centerwatch.com/products/category/1105-books/product/547

Ever wanted to read the other side’s mind during clinical trial agreement (CTA) negotiations?

Perspectives on Clinical Trial Agreements: What Sites, Sponsors and Stakeholders Need gives readers a view of the other side that improves one’s bargaining position. Readers will know when to push, when to hold off and when to walk away, in a process that’s a collaboration among parties with shared interests.

Based on presentations by multiple subject matter experts at MAGI’s Clinical Research vConference — Spring 2021, Perspectives on Clinical Trial Agreements reveals how to negotiate the most advantageous contracts possible:

• 
  The relationships among the various parties to a CTA
• The meaning of key terms
• The structure and scope of a CTA
• How to craft individual sections of a CTA, including:

     o Records storage and maintenance

     o Indemnification and liability

     o Publishing study results

     o Ownership of data and intellectual property

     o Debarment and exclusion

CTA negotiations will be effortless when one knows what the other side is thinking. Perspectives on Clinical Trial Agreements: What Sites, Sponsors and Stakeholders Need gets one there.

Management Report Details:

Perspectives on Clinical Trial Agreements:

What Sites, Sponsors and Stakeholders Need

CenterWatch Management Report

https://www.centerwatch.com/products/category/1105-books/product/547

Price:

$397

Easy Ways to Order:

Online: https://www.centerwatch.com/products/category/1105-books/product/547

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

WCG FDAnews

FALLS CHURCH, Va. (PRWEB)
September 30, 2021

Consumer Diagnostics and Wellness Testing:

Navigating the Medical Device Regulations

An FDAnews Webinar

Tuesday, Oct. 5, 2021, 1:30 p.m.-3:00 p.m. EDT

https://wcg.swoogo.com/consumer-diagnostics-and-wellness-testing

One thing the pandemic proved: the public is increasingly reliant on consumer diagnostics and wellness testing.

With no signs of waning demand, companies are scrambling to get offerings to market. The main challenge? What the regulatory, enforcement and policy future brings.

Mahnu Davar, a partner at Arnold and Porter in the life sciences and healthcare regulatory practice, will explain the next-generation enforcement approach in consumer diagnostics. Attendees will skillfully navigate this changing landscape when he shares:

• The basics of FDA regulation of diagnostics products and components, including FDA’s enforcement discretion policy for lab-developed tests
• How FDA applies medical device regulatory requirements to test kits and component developments
• The interaction between telehealth and prescription diagnostics/diagnostic ordering regulations, including state medical practice laws, the Clinical Laboratory Improvement Amendments (CLIA) and FDA’s regulation of prescription devices
• How FDA enforces its requirements in this area and what liability considerations you may face for noncompliance, including liability for marketing unapproved/uncleared, adulterated or misbranded products
• How the COVID-19 pandemic and its lessons learned may shape how regulators will deal with issues involving consumer diagnostics going forward

Clarity on forthcoming regulatory, enforcement and policy issues regarding consumer diagnostics is here. Don’t miss out.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

Consumer Diagnostics and Wellness Testing:

Navigating the Medical Device Regulations

An FDAnews Webinar

Tuesday, Oct. 5, 2021, 1:30 p.m.-3:00 p.m. EDT

https://wcg.swoogo.com/consumer-diagnostics-and-wellness-testing

Tuition:

$297 per site

Easy Ways to Register:

Online: https://wcg.swoogo.com/consumer-diagnostics-and-wellness-testing

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

“We are bridging the gap between Austin and Waco, to extend the compassionate care and support that Heart to Heart provides throughout the state.”

PLANO, Texas (PRWEB)
September 30, 2021

Heart to Heart Hospice, one of the country’s largest private providers of hospice care, has added a new location in Temple, Texas, expanding its service to those living in Central Texas.

The new Temple site was recently opened to help meet the needs of more patients and families in the Central Texas service area. That area, with offices already located in Cleburne and Austin, covers the counties of Bell, Coryell, Falls, Lampasas, McLennan, Mills, San Saba, and Williamson.

“This is a fast-growing area that has been directly underserved with hospice,” said Greg Drummond, Heart to Heart’s Vice President of Sales for Texas. “We are bridging the gap between Austin and Waco, to extend the compassionate care and support that Heart to Heart provides throughout the state.”

The new site is located at: 990 Marlandwood Road in Temple. Phone: 254.493.8448

Since 2003, Heart to Heart Hospice has been serving patients with life-limiting illnesses, as well as their loved ones, across Texas, and in Michigan and Indiana.

“When medicine cannot provide a cure, hospice redefines hope in terms of a patient’s quality of life,” said Kelly Mitchell, Chief Executive Officer and Founder of Heart to Heart Hospice. Through a team-oriented approach, Heart to Heart cares for the whole person, noted Mitchell. “We meet each patient’s unique needs, while also supporting their caregivers with guidance and encouragement to help make the time together as peaceful as possible,” he added.

“Helping our patients remain in the place they call home and keeping them comfortable is what the Heart to Heart care team is trained to do,” said Heather Lumsdon, BSN, RN and Chief Clinical Officer of Heart to Heart Hospice. “We develop a personalized care plan that will honor their wishes and values and truly make a difference for them and their families.”

About Heart to Heart Hospice

Heart to Heart Hospice, founded in 2003, is one of the largest private providers of hospice care in the United States. Headquartered in the Dallas-Fort Worth Metroplex, Heart to Heart provides a broad range of hospice services to patients with life-limiting illnesses across 52 locations in Texas, Michigan, and Indiana. At Heart to Heart, we understand both the physical and emotional challenges for our patients and their loved ones and our compassionate care team is committed to providing them with what they need most: comfort, support, and dignity. Learn more about Heart to Heart Hospice.

Share article on social media or email:

Regroup Wins 2021 SSI Award

Industry leader in cloud-based mass notification recognized for performance in the field of emergency notifications and alerts.

DALLAS (PRWEB)
September 30, 2021

Regroup Mass Notification, an industry-leading provider of emergency and day-to-day communication solutions, announced today that Security Sales & Integration, the security industry’s premier technology and business source, has named Regroup a 2021 Security Solutions Award winner.

The announcement came at this year’s Global Security Exchange (GSX) conference in Orlando, Florida.

This prestigious award is given to a select group of technology companies and device manufacturers who have demonstrated top performance in actual field deployments over the past 12 months.

Entrants in the Security Solutions Awards are judged on how well their products meet the real-world needs of security companies in application, innovation, functionality and value. Regroup’s cloud-based mass notification system has become a popular choice for security professionals and their clients due to its rapid delivery, ease of use and reliability.

“Regroup is continually striving to outdo itself in innovation and value,” said Chris Utah, COO of Regroup. “We understand that the needs of our clients are constantly expanding, and we’re leading the way in addressing those needs by providing communication technology that evolves and adapts.”

Regroup’s advanced features like geo-targeting, native mobile app, a recently introduced threat intelligence suite and numerous integrations made it a clear winner in Security Sales & Integrations’ award program. Additionally, Regroup has demonstrated continuous improvement and commitment to keeping people safe and informed during uncertain times with features such as active COVID-19 mapping capabilities.

Winners of the 2021 Security Solutions Award have been announced online at Security Sales and Integration’s website.

To learn more about Regroup’s award-winning platform, visit regroup.com.

About Regroup Mass Notification

Regroup Mass Notification empowers better mass communication, keeping people safe and informed at all times. The company’s award-winning, cloud-based mass communication platform is what clients across North America and around the globe rely on to send both emergency and day-to-day communications to millions of people. By enabling one-click messaging to mobile devices, landlines, social media, email, websites and more, Regroup Mass Notification helps organizations keep people safe, strengthen operational resilience, mitigate risk and thrive in an increasingly unpredictable world.

Share article on social media or email:

Shona Murray, M.D., who sees patients at SGF Colorado’s Colorado Springs office, has been recognized as a Colo|Spgs Magazine 2021 Top Doctor for Infertility.

“Thank you, Colorado Springs patients, for entrusting me with your fertility care, and thank you to my physician peers for recognizing me as a Top Doctor in my field.”

COLORADO SPRINGS, Colo. (PRWEB)
September 30, 2021

Shady Grove Fertility (SGF) is proud to announce that Shona Murray, M.D., who sees patients at SGF’s Colorado Springs office, has again been named to Colo|Spgs Magazine’s 2021 Top Doctors list following multiple distinctions since her first recognition in 2011.

Colo|Spgs Magazine, previously known as Colorado Springs Style, conducts an annual peer-to-peer survey by Perini & Associates, an independent firm with no ties to the magazine or the medical community. Out of 654 Fayette County Medical Society members surveyed, 220 active Colorado Springs doctors representing 70 practice areas of medicine, who are members in good standing with the El Paso County Medical Society, will be published in the 2021 Top Doctor list.

“Every patient I meet inspires me,” shares Dr. Murray “I find such joy in developing a treatment plan that helps my patients conceive. Thank you, Colorado Springs patients, for entrusting me with your fertility care, and thank you to my physician peers for recognizing me as a Top Doctor in my field. I am honored to be named along so many great physicians in our community.”

Get to Know Dr. Murray and SGF Colorado Springs

Dr. Murray is board certified in obstetrics and gynecology and board eligible in reproductive endocrinology and infertility (REI). She specializes in the diagnosis and treatment of infertility, including polycystic ovary syndrome (PCOS), anovulation, male factor infertility, and tubal disease.

Living in Colorado Springs, Dr. Murray particularly enjoys working with military families. Dr. Murray is a member of several professional organizations, including the American Society for Reproductive Medicine (ASRM), the American Congress of Obstetricians and Gynecologists (ACOG), Society for Reproductive Endocrinology and Infertility, and Fayette County Medical Society.

A patient of Dr. Murray’s at the Colorado Springs office has shared, “Although I am thrilled to have graduated from Shady Grove Fertility because I am pregnant, I can’t deny being just a little sad to leave the practice. That’s how good my experience was. I especially appreciated Dr. Murray’s evidence-based approach and her in-depth explanations of every process, procedure and recommendation. She really listened to my concerns and situation, always made herself available to answer my many questions, and made certain I had a realistic view of my unexplained infertility.”

The Colorado Springs location offers comprehensive fertility services, including:

• 
  fertility and ovarian reserve testing and diagnosis,
• semen analysis,
• hysterosalpingogram (HSG),
• low-tech fertility treatment options such as intrauterine insemination (IUI),
• in vitro fertilization (IVF),
• donor egg, sperm, and embryo,
• genetic screening and testing,
• gestational carrier,
• egg freezing,
• fertility preservation for patients with cancer, and
• LGBTQ family building.

Given the staggering fact that one in eight couples of reproductive age are in need of fertility care, it’s reassuring that SGF Colorado offers an expansive insurance network as well as unique financial programs for self-pay patients. Their hallmark program, the Shared Risk 100% Refund Guarantee Program, offers patients the reassurance they will either take home a baby or receive a full refund. SGF also provides income-based and military discounts, to name a few, as well as an exclusive financing partner, Fertility Finance.

New patients may schedule an appointment with Dr. Murray at the Colorado Springs office by calling the SGF New Patient Center at 720-778-3810 or submitting this brief online form.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born. With 42 locations, including new locations in Colorado and Norfolk, VA, as well as throughout CO, FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, SGF offers patients virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment more affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. SGF is among the founding partner practices of US Fertility, the largest physician-owned, physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

Share article on social media or email:

Dr. Anthony Bared

“Many people assume you have to be 18 or 21 to have a rhinoplasty done, but, in the US alone, over 30,000 rhinoplasties are performed on teens ages 15-19 each year,” said Dr. Bared.

MIAMI (PRWEB)
September 30, 2021

The results of a rhinoplasty performed by Dr. Anthony Bared, M.D., F.A.C.S., has gone viral after a happy young patient of his posted a video of her recovery on TikTok. The video, which has garnered millions of views and likes, has helped bring attention and acceptance to the topic of cosmetic procedures among teens and young adults.

“Myself and my staff were excited to see our young patient comfortably share her journey with her peers on social media,” said Dr. Bared. “Teen and young adult rhinoplasty is actually a common procedure that we perform at my practice. The procedure is extremely safe and is the most common facial plastic surgery.”

Dr. Bared and the staff at his clinic, Anthony Bared Facial Plastic Surgery Miami, are considered an “excellent choice” to perform rhinoplasties that are appropriate for teens and young adults.

This is “the best experience and service I have received in a long time. I’m very happy with my results and that is thanks to Dr. Bared for being so detailed and the best at what he does,” wrote one five-star reviewer.

“Here I am almost 5 weeks after surgery and I kid you not, I am a different person! …My confidence boost is enough to put me to tears! I cried when they took off my cast because my nose – my whole face – has never looked more amazing!!!! I cannot stress enough how much I love this doctor.” wrote another five-star reviewer.

Dr. Bared urges teens and young adults interested in rhinoplasty to book a consultation with his office to discuss the possibilities and whether the procedure is right for them.

“Many people assume you have to be 18 or 21 to have a rhinoplasty done, but, in the US alone, over 30,000 rhinoplasties are performed on teens ages 15-19 each year,” said Dr. Bared.

Dr. Bared’s practice, Facial Plastic Surgery Miami, stresses that teens and young adults should make an appointment to come in with a parent or guardian to talk over the details, including expected results, and to get more information on how the procedure is performed.

To learn more about teen and young adult rhinoplasty and to see the full list of services performed at Dr. Bared’s clinic, visit his website at http://www.facialplasticsurgery.com.

About Dr. Anthony Bared

Dr. Anthony Bared, M.D., F.A.C.S., is a celebrated double board-certified Miami-based facial plastic surgeon with certification from the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology/ Head and Neck Surgery. Known for his surgical skill and caring and comprehensive approach to patient care, Dr. Bared is one of the most trusted names among Miami plastic surgeons.

Share article on social media or email: